Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gertner

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The British Journal of Ophthalmology|August 17, 2012
16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategyAndrew A Moshfeghi, Virgilio Morales-Canton, Hugo Quiroz-Mercado, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategyAndrew A Moshfeghi, Virgilio Morales Canton, Hugo Quiroz-Mercado, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Seminars in Pediatric Surgery|October 24, 2006
Inventing our future: training the next generation of surgeon innovatorsThomas M Krummel, Michael Gertner, Josh Makower, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Biological Psychiatry|December 18, 2009
Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disordersTakeshi Sakurai, Nicolas Ramoz, Marta Barreto, et al.
Journal of Hypertension|October 17, 2017
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IVRoland E Schmieder, Christian Ott, Stefan W Toennes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The British Journal of Ophthalmology|August 17, 2012
16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategyAndrew A Moshfeghi, Virgilio Morales-Canton, Hugo Quiroz-Mercado, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategyAndrew A Moshfeghi, Virgilio Morales Canton, Hugo Quiroz-Mercado, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Seminars in Pediatric Surgery|October 24, 2006
Inventing our future: training the next generation of surgeon innovatorsThomas M Krummel, Michael Gertner, Josh Makower, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|August 12, 2011
16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomesVirgilio Morales Canton, Hugo Quiroz-Mercado, Raul Velez-Montoya, et al.
Biological Psychiatry|December 18, 2009
Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disordersTakeshi Sakurai, Nicolas Ramoz, Marta Barreto, et al.
Journal of Hypertension|October 17, 2017
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IVRoland E Schmieder, Christian Ott, Stefan W Toennes, et al.
Pageof 3